These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25792087)

  • 1. Methods used in preclinical assessment of anti-Buruli ulcer agents: A global perspective.
    Tsouh PV; Addo P; Yeboah-Manu D; Boyom FF
    J Pharmacol Toxicol Methods; 2015; 73():27-33. PubMed ID: 25792087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buruli ulcer: a review of in vitro tests to screen natural products for activity against Mycobacterium ulcerans.
    Yemoa A; Gbenou J; Affolabi D; Moudachirou M; Bigot A; Anagonou S; Portaels F; Quetin-Leclercq J; Martin A
    Planta Med; 2011 Apr; 77(6):641-6. PubMed ID: 21240839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnopharmacological reports on anti-Buruli ulcer medicinal plants in three West African countries.
    Tsouh Fokou PV; Nyarko AK; Appiah-Opong R; Tchokouaha Yamthe LR; Addo P; Asante IK; Boyom FF
    J Ethnopharmacol; 2015 Aug; 172():297-311. PubMed ID: 26099634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial activity and in vivo efficacy of hydrated clays on Mycobacterium ulcerans growth.
    Adusumilli S; Haydel SE
    BMC Complement Altern Med; 2016 Jan; 16():40. PubMed ID: 26833071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid, serial, non-invasive assessment of drug efficacy in mice with autoluminescent Mycobacterium ulcerans infection.
    Zhang T; Li SY; Converse PJ; Grosset JH; Nuermberger EL
    PLoS Negl Trop Dis; 2013; 7(12):e2598. PubMed ID: 24367713
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kwofie SK; Dankwa B; Odame EA; Agamah FE; Doe LPA; Teye J; Agyapong O; Miller WA; Mosi L; Wilson MD
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29954088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Informatics Studies of the Iron-Dependent Regulator (ideR) Reveal Potential Novel Anti-
    Kwofie SK; Enninful KS; Yussif JA; Asante LA; Adjei M; Kan-Dapaah K; Tiburu EK; Mensah WA; Miller WA; Mosi L; Wilson MD
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31234337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana].
    Sambourg E; Dufour J; Edouard S; Morris A; Mosnier E; Reynaud Y; Sainte-Marie D; Nacher M; Guégan JF; Couppié P
    Ann Dermatol Venereol; 2014; 141(6-7):413-8. PubMed ID: 24951139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection).
    Walsh DS; Portaels F; Meyers WM
    Curr Opin Infect Dis; 2010 Oct; 23(5):445-55. PubMed ID: 20581668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment.
    Scherr N; Pluschke G; Thompson CJ; Ramón-García S
    PLoS Negl Trop Dis; 2015 Aug; 9(8):e0003996. PubMed ID: 26270480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
    Walsh DS; Portaels F; Meyers WM
    Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
    Nienhuis WA; Stienstra Y; Thompson WA; Awuah PC; Abass KM; Tuah W; Awua-Boateng NY; Ampadu EO; Siegmund V; Schouten JP; Adjei O; Bretzel G; van der Werf TS
    Lancet; 2010 Feb; 375(9715):664-72. PubMed ID: 20137805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.
    Silva MT; Portaels F; Pedrosa J
    Lancet Infect Dis; 2009 Nov; 9(11):699-710. PubMed ID: 19850228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should antibiotics be given for Buruli ulcer?
    Johnson PD
    Lancet; 2010 Feb; 375(9715):618-9. PubMed ID: 20137806
    [No Abstract]   [Full Text] [Related]  

  • 15. Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig Model.
    Silva-Gomes R; Marcq E; Trigo G; Gonçalves CM; Longatto-Filho A; Castro AG; Pedrosa J; Fraga AG
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004265. PubMed ID: 26625302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short report: Clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya.
    Walsh DS; Eyase F; Onyango D; Odindo A; Otieno W; Waitumbi JN; Bulimo WD; Schnabel DC; Meyers WM; Portaels F
    Am J Trop Med Hyg; 2009 Dec; 81(6):1110-3. PubMed ID: 19996445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buruli ulcer in an 18-day-old baby.
    Kiiza AM; Wood PB
    Trop Doct; 2012 Jan; 42(1):48. PubMed ID: 22080481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice].
    Nakanaga K; Saito H; Ishii N; Goto M
    Kekkaku; 2004 May; 79(5):333-9. PubMed ID: 15211873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buruli ulcer and current situation in Japan: a new emerging cutaneous Mycobacterium infection.
    Yotsu RR; Nakanaga K; Hoshino Y; Suzuki K; Ishii N
    J Dermatol; 2012 Jul; 39(7):587-93. PubMed ID: 22486235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and histologic features of skin lesions in a cynomolgus monkey experimentally infected with mycobacterium ulcerans (Buruli ulcer) by intradermal inoculation.
    Walsh DS; Dela Cruz EC; Abalos RM; Tan EV; Walsh GP; Portaels F; Meyers WM
    Am J Trop Med Hyg; 2007 Jan; 76(1):132-4. PubMed ID: 17255241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.